Dyadic International (NASDAQ:DYAI) Posts Earnings Results, Misses Estimates By $0.01 EPS

Dyadic International (NASDAQ:DYAIGet Free Report) posted its quarterly earnings results on Wednesday. The biotechnology company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.01), Zacks reports. Dyadic International had a negative return on equity of 149.16% and a negative net margin of 188.09%.

Dyadic International Trading Down 3.6 %

DYAI traded down $0.05 during midday trading on Wednesday, reaching $1.33. 27,842 shares of the company were exchanged, compared to its average volume of 68,808. The stock has a market capitalization of $39.35 million, a P/E ratio of -5.78 and a beta of 0.95. Dyadic International has a one year low of $0.93 and a one year high of $2.67. The stock’s 50-day simple moving average is $1.48 and its 200 day simple moving average is $1.42. The company has a debt-to-equity ratio of 1.54, a quick ratio of 5.15 and a current ratio of 5.15.

Institutional Trading of Dyadic International

An institutional investor recently raised its position in Dyadic International stock. Bank of America Corp DE raised its position in Dyadic International, Inc. (NASDAQ:DYAIFree Report) by 16,146.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 27,132 shares of the biotechnology company’s stock after purchasing an additional 26,965 shares during the period. Bank of America Corp DE owned approximately 0.09% of Dyadic International worth $47,000 as of its most recent filing with the SEC. 27.95% of the stock is currently owned by hedge funds and other institutional investors.

Dyadic International Company Profile

(Get Free Report)

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.

Featured Stories

Earnings History for Dyadic International (NASDAQ:DYAI)

Receive News & Ratings for Dyadic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dyadic International and related companies with MarketBeat.com's FREE daily email newsletter.